Inactive Instrument

Human Genome Sciences Stock

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

27/07/12	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	RE
16/07/12	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE

27/07/12	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	RE
16/07/12	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE
16/07/12	GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	RE
15/07/12	GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	RE
03/07/12	GlaxoSmithKline plc : GSK lines up nominees for Human Genome board	RE
29/06/12	GlaxoSmithKline plc : GSK further extends $2.6 billion Human Genome offer	RE
08/06/12	GlaxoSmithKline plc : GSK extends its $2.6 billion offer for Human Genome	RE
01/06/12	GlaxoSmithKline plc : Court denies request to curb Human Genome takeover defense	RE
31/05/12	Genmab A/S : Exclusive: GlaxoSmithKline eyes replacing Human Genome board	RE
30/05/12	GlaxoSmithKline plc : Exclusive: GSK eyes replacing Human Genome board	RE
23/05/12	GlaxoSmithKline plc : GSK to drop Human Genome bid if "poison pill" stands	RE
09/05/12	SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	RE
02/05/12	Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	RE

04/08/12	Human Genome Sciences : ANNOUNCES REQUIRED OFFER TO REPURCHASE IN RESPECT OF ITS 3.00% CONVERTIBLE SENIOR NOTES DUE 2018	PU
26/07/12	Human Genome Sciences : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.	PR
20/07/12	Human Genome Sciences : Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breaches of Fiduciary Duty	BU
18/07/12	Human Genome Sciences : Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.	PR
17/07/12	Human Genome Sciences : Inc. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow & Goldberg LLP	BU

25/07/12	GlaxoSmithKline plc : GlaxoSmithKline-T2 inférieur aux attentes, baisse du titre
16/07/12	GSK rachète Human Genome pour 3,0 milliards de dollars
16/07/12	GSK annonce le rachat de Human Genome pour $3,0 milliards
16/07/12	Human Genome : grimpe avec la nouvelle offre de GSK.
16/07/12	Wall Street ouvre en léger recul, mais Citi monte

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.68%	+3.19%	+3.55%	+10.22%	49.42B
REVOLUTION MEDICINES, INC.	+1.59%	+1.83%	+400.26%	+608.20%	40.34B
IQVIA HOLDINGS INC.	+1.80%	+0.15%	+27.98%	-5.50%	34.01B
BEONE MEDICINES AG	+0.59%	+2.00%	+18.73%	+57.68%	33.56B
CELLTRION, INC.	-2.09%	-0.80%	+3.56%	+33.56%	26.84B
ASCENDIS PHARMA A/S	+0.03%	+0.91%	-	-	17.22B
MEDPACE HOLDINGS, INC.	+0.02%	-4.55%	+65.82%	+120.11%	15.19B
IONIS PHARMACEUTICALS, INC.	-23.63%	-20.99%	+50.90%	+54.69%	13.96B
EUROFINS SCIENTIFIC SE	+2.59%	-0.49%	+15.24%	+20.83%	13.36B
Average	-1.97%	+0.83%	+73.26%	+112.47%	27.1B
Weighted average by Cap.	-0.54%	+0.90%	+87.85%	+134.80%